Bonjour, new guests from small-town India
Puneet Dhawan of Accor is brimming with ideas on ways to revive the hospitality sector
New findings suggest that almost all Covid-19 survivors have the immune cells necessary to fight re-infection.
The findings, based on analyses of blood samples from 188 Covid-19 patients, revealed that responses to the novel coronavirus from all major players in the “adaptive” immune system, can last for at least eight months after the onset of symptoms from the initial infection.
Lead author, LJI Professor, Alessandro Sette, said in a statement: “Our data suggest that the immune response is there — and it stays.”
Studies find having Covid-19 may protect against reinfection
Co-author, Professor Shane Crotty, Ph.D., and LJI Research Assistant Professor Daniela Weiskopf, said: “We measured antibodies, memory B cells, helper T cells and killer T cells all at the same time. As far as we know, this is the largest study ever, for any acute infection, that has measured all four of those components of immune memory.”
The findings, published in the journal Science, stated that Covid-19 survivors have protective immunity against serious disease from the SARS-CoV-2 virus for months, perhaps years after infection.
The new study helps clarify some concerns over Covid-19 data from other labs, which showed a dramatic drop-off of Covid-fighting antibodies in the months following infection. Some feared that this decline in antibodies meant that the body wouldn’t be equipped to defend itself against reinfection.
Russian doctor surrounded himself with COVID-19 patients to test reinfection
Sette explained that a decline in antibodies is very normal. “Of course, the immune response decreases over time to a certain extent, but that’s normal. That’s what immune responses do. They have a first phase of ramping up, and after that fantastic expansion, eventually, the immune response contracts somewhat and gets to a steady state,” Sette said.
The researchers found that virus-specific antibodies do persist in the bloodstream months after infection. Importantly, the body also has immune cells called memory B cells at the ready. If a person encounters SARS-CoV-2 again, these memory B cells could reactivate and produce SARS-CoV-2 antibodies to fight re-infection.
The SARS-CoV-2 virus uses its “spike” protein to initiate infection of human cells, so the researchers looked for memory B cells specific for the SARS-CoV-2 spike. They found that spike-specific memory B cells actually increased in the blood six months after infection.
“This implies that there’s a good chance people would have protective immunity, at least against serious disease, for that period of time, and probably well beyond that,” said Crotty.
The team cautions that protective immunity does vary dramatically from person to person. In fact, the researchers saw a 100-fold range in the magnitude of immune memory. People with a weak immune memory may be vulnerable to a case of recurrent Covid-19 in the future, or they may be more likely to infect others.
“There are some people that are way down at the bottom of how much immune memory they have, and maybe those people are a lot more susceptible to reinfection,” Crotty added.
“It looks like people who have been infected are going to have some degree of protective immunity against reinfection,” added Weiskopf. “How much protection remains to be established.”
The researchers will continue to analyse samples from Covid-19 patients in the coming months and hope to track their responses 12 to 18 months after the onset of symptoms.
Puneet Dhawan of Accor is brimming with ideas on ways to revive the hospitality sector
Citroen’s first vehicle sports a novel design and European interiors. It is also meant to be as comfortable as ...
The pandemic is only the tip of the iceberg that the country’s cash-poor airlines — both regional and national ...
The government is yet to specify the framework of its recently announced old vehicle scrappage policy
Here is a checklist that equips you to discern the market nuances
Sensex, Nifty 50 have witnessed sharp decline
The fund has consistently outperformed S&P BSE 100 TRI over one, three and five years
Returns are superior to immediate annuity plans, but SCSS can secure better rates for new investors sooner if ...
They are the health warriors who battled the Covid-19 pandemic on the ground, and are now the face of the ...
Reading in the loo — flipping through anything, really — appears to help the locomotion
Creator of the world’s biggest art canvas hopes to help children in poorer countries
A book on Badri Narayan is a tribute — albeit a belated one — to an artist who did not enjoy the recognition ...
Its name is the starting point of a brand’s journey and can make a big difference in the success sweepstakes
Sober spirits are the in thing
A peek into where ad spends went last year and where they are headed tomorrow
Can Swiggy Instamart disrupt the ecommerce groceries space, currently ruled by the Amazons and Big Baskets? ...
Three years after its inception, compliance with GST procedures remains a headache for exporters, job workers ...
Corporate social responsibility (CSR) initiatives of companies are altering the prospects for wooden toys of ...
Aequs Aerospace to create space for large-scale manufacture of toys at Koppal
And it has every reason to smile. Covid-19 has triggered a consumer shift towards branded products as ...
Please Email the Editor